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Objective: To investigate whether women presenting with suspected angina would show less severe coronary
artery disease in than men as determined by the extent score.
Methods:We examined 994 participants of the Australian Heart Eye Study presenting for coronary angiography
in the investigation of chest pain from June 2009 to February 2012. People were excluded if therewas a history of
coronary artery bypass surgery, previous stenting procedure or incomplete angiogram scoring. An extent and
vessel score was calculated using invasive coronary angiography. Normal coronary arteries were deﬁned as
having no luminal irregularity (Extent score = 0). Obstructive coronary artery disease was deﬁned as a luminal
narrowing of greater than 50%.
Results:Women compared to men without infarction had a lower burden of CAD with up to 50% having normal
coronary arteries in the 30–44 year group and40% in the 45–59 year group. Compared tomen,womenwith chest
pain had lower mean extent scores (19.6 vs 36.8; P b 0.0001) and lower vessel scores (0.7 v 1.3; P b 0.0001).
Although the mean extent score was lower in women than men with myocardial infarction, this was not
statistically signiﬁcant (34.8 vs 41.6 respectively; P = 0.18).
Conclusion: There is amarkeddifference in coronary artery disease severity and burdenbetween females andmales
presenting for the investigation of suspected angina. Women are more likely to have normal coronary arteries or
less severe disease than age-matched men, particularly if they do not present with myocardial infarction.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cardiovascular disease, in particular coronary disease, is the leading
cause of mortality in women. In fact, women are more likely to die
following a myocardial infarct than men [1]. Despite this, the pattern
of coronary artery disease (CAD) is substantially different between
men and women [2]. Up to 60% of women and 30% of menwho present
with angina have either normal arteries or non-obstructive lesions
[3–5]. Women present with less obstructive epicardial stenoses and
more diffuse atherosclerosis and microvascular dysfunction [6].
Women can display evidence of ischemia on functional assessment
(such as pressure wire studies, myocardial perfusion imaging and
magnetic resonance imaging) without obstructive epicardial coronary
disease. This may be unrelated to the presence of Framingham risk
factors [7–9]. Women also demonstrate a higher prevalence ofiversity of Sydney,Department
stmead, NSW 2145, Australia.
.
liability and freedom from bias
land Ltd. This is an open access articlatherosclerosis with positive remodeling and preserved lumen size as
demonstrated by intravascular ultrasound [9,10].
The Australian Heart Eye Study (AHES) was a large cross-sectional
study of patients presenting for coronary angiography in the investiga-
tion of chest pain atWestmeadHospital, Sydney, Australia. It was devel-
oped to study the relationship between gender and both retinal vascular
disease and CAD. We investigated the anatomical relationship between
angiographically proven CAD and gender in this population using
the extent score. The extent score reﬂects the proportion of the
coronary tree with angiographically detectable atherosclerotic disease,
scaled according to the functional signiﬁcance of the involved artery
[11]. There are no studies to our knowledge that use the extent score
to describe the anatomical burden of CAD in men compared to
women. We hypothesized that women with chest pain would show
less severe CAD in all age groups than men.
2. Methods
2.1. Study population
TheAustralianHeart Eye Study (AHES) recruited patients presenting
to Westmead Hospital for the assessment of suspected CAD betweene under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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externally referred for investigation and the decision to pursue angiog-
raphy was made by the referrer who was unaware of any subsequent
participation in the study. Participants were consented to the study
prior to or following invasive coronary angiography, and included
1680 patients, who were interviewed to obtain data on demographic
characteristics, medical history and behavioral habits. The presence of
risk factors was determined either by physician diagnosis or treatment
for the medical condition. Medical records were reviewed to obtain
medication use and conﬁrm medical history. Of the 1680 examined in
this study, a total of 398 participants were excluded because they had
a previous history of coronary artery bypass grafting (n = 191) and/or
previous coronary artery stent (n = 298). If there was incomplete
background information or if an extent score was not able to measured
due to suboptimal angiogram quality, these participants were also
excluded. A total of 994 participated (712 men and 282 women). Of
those presenting with chest pain, 221 (187 men and 34 women) were
diagnosed with myocardial infarction. This was based on symptoms of
ischemia, characteristic electrocardiographic ﬁndings, elevation in
cardiac troponin enzyme.
The study protocol conforms to the ethical guidelines of the 1975
declaration of Helsinki and ethical approval was obtained from the
Western Sydney Local Health Network Human Research Ethics
Committee (Westmead).
2.2. Coronary angiography image acquisition and analysis
Diagnostic coronary angiography was performed via a femoral or
radial approach using a catheter of known dimension. The technique
employed was determined by vascular accessibility of the patient and
operator preference. Selective coronary injections were ﬁlmed in stan-
dard projections with a Siemens Bi-Plane radiographic unit (Siemens
Healthcare, Germany). All angiograms were ﬁlmed at 15 frames/s and
cine runs were stored at the time of acquisition in DICOM format.
All angiograms were masked to patient name and diagnosis.
Analysis was performed ofﬂine by a cardiologist (author J.C.) blinded
to the results of the adjunctive investigations. Two orthogonal views
were examined in end-diastole to maximize contrast enhancement
and vessel diameter. The image with the most severe stenosis was
used for each evaluated segment of the coronary artery tree. For each
segment, the severity of obstruction was documented using several
grades: normal, 1–25%, 25–50%, 50–74%, 75–99% and 100% (occluded).
Each lesion that was visually scored as greater than 50% luminal
obstruction in a vessel that was ≥1.5 mm diameter, was further
analyzed using validated computerized edge-detection software
(QCAPLUS, Sanders data Systems, Palo Alto, California, USA) to allow
more accurate assessment and classiﬁcation of lesion severity. Catheters
of known diameter were used for calibration. Coronary angiograms
were scored according to two methods. The analyzing cardiologist was
masked to patient medical history and investigation results.
1) Vessel score: A vessel score was calculated based on the number of
vessels with signiﬁcant obstructive coronary disease. The 2011
American College of Cardiology (ACC) taskforce deﬁnition uses 50%
stenosis to deﬁne signiﬁcant vessel disease [12]. This deﬁnition
was used for the left main coronary artery, right coronary, left
anterior descending and left circumﬂex arteries. Scores ranged
from 0 to 4, depending on a ﬁnding of vessels with greater than
50% stenosis [13]. Left main artery stenosis was scored as double
vessel disease.
2) Extent score: This score, proposed by Sullivan et al. deﬁnes the
proportion of the coronary artery tree involved by angiographically
detectable coronary atheroma [11]. The proportion of each vessel
involved by atheroma, identiﬁed by lumen irregularity, was multi-
plied by a factor for each vessel, related to the length of that vessel.
The scores for each vessel were added to give a total score out of100. This percentage represents the proportion of the coronary
intimal surface area containing coronary atheroma [11].
To assess the inter-observer and intra-observer variation in the
coronary angiography analysis, 40 random cases were selected. None
of the observers participated in the selection of the angiograms and
weremasked to patient name and diagnosis.We used the Bland Altman
method to evaluate reproducibility and inter-observer reliability of the
extent score [14]. The bias was 0.15 (limit of agreement −1.77 to
2.06) for intra-observer reproducibility. For inter-observer difference
the bias was 0.076 (limit of agreement−1.74 to 1.25).
2.3. Statistical analysis
Continuous variables are presented as means (SD or SE) and
categorical variables are presented as proportions (%). SAS statistical
software (SAS Institute, Cary NC) version 9.2 was used for analyses.
The Bland Altman method was performed to evaluate the inter- and
intra-variability of the Extent score grading. Analyses performed included
t-tests, chi-squared (χ2)-tests and generalized linear models, binary and
generalized logistic regression models. Pearson's correlation coefﬁcients
were used to correlate the discontinuous and non-normally distributed
data. We performed a Kolmogorov–Smirnov test for extent scores that
showed a signiﬁcant difference between gender (P b 0.0001) with
women having lower scores than men. We chose to stratify all analyses
by sex and age for this study. Both continuous and categorical data
were used to present the extent score. Multivariable logistic regression
models (binary and generalized) were used to assess the association
between gender, age and extent scores. Extent scores were expressed
as ordinal categories ranging from 0 (no disease) to 1, 2, and 3 (corre-
sponding to the ﬁrst, second and third tertiles among those who had
disease). The tertile ranges for extent score were 0.3 to 10.7, 11.1 to
33.6 and 33.7 to 100 for the female population and 0.7 to 25.5, 25.7 to
59.6 and 59.6 to 100 in the males. Independent t-tests were used to
compare the extent and vessel scores between infarct and non-infarct
groups and in our models, data were adjusted for the potential inﬂuence
of signiﬁcant covariates: age, mean arterial blood pressure, body mass
index, dyslipidemia, smoking, hypertension, presence of type 2 diabetes
and treatment with calcium-channel blockers and nitrates. P-values
b0.05 were considered statistically signiﬁcant.
3. Results
3.1. Patient characteristics
The study cohort was predominantly male (73%) with an average
age of 60.3 years and Caucasian background (Table 1). Men were
more likely to give a history of smoking. In contrast, more women had
a history of dyslipidemia, hypertension and diabetes. Body mass index
and waist to height ratio were both greater in women (P b 0.0001).
3.2. Angiographic scoring and correlations by gender
Themean extent and vessel scores were higher in men than women
(Table 2). Correlation analysis showed a strong positive linear relation-
ship between each of the scoring systems used. The correlation was
higher in men (r = 0.78–0.94, P b 0.0001) than in women (r = 0.67–
0.9, P b 0.0001). Compared to women, men had signiﬁcantly increased
the odds of having an extent score not equal to zero (Table 3).
3.3. Extent scores and relationship to gender and age
Fig. 1 is a graphical representation of the extent scores by age and
gender. There were proportionally more women with normal coronary
arteries than men and a slow tapering with age. By contrast, men had a
lower proportion of normal arteries and had signiﬁcant coronary
Table 1
Demographic and clinical characteristics of participants stratiﬁed by gender.
Characteristics
Women
(n = 282)
Men
(n = 712)
P-value
Sex (%) 28 72 b0.0001
Age, yrs 63.8 (10.9) 60.3 (11.9) b0.0001
Ethnicity
Caucasian 253 (72.1) 651 (66.6) 0.0164
East Asian 18 (5.1) 64 (6.6)
Southeast Asian 20 (5.7) 90 (9.2)
Middle Eastern 25 (7.1) 104 (1.6)
Others 35 (10) 68 (7)
Body Height, m 1.58 (0.1) 1.71 (0.1) b0.0001
Body Weight, kg 75.9 (16.4) 86.7 (18.5) b0.0001
BMI, kg/m2 30.3 (6.5) 29.4 (5.7) 0.03
Waist:height ratio 62.3 (9.6) 59.3 (8.2) b0.0001
Blood Pressure (mm Hg)
Systolic 125.9 (21.8) 128.3 (19.2) 0.0749
Diastolic 71.9 (12.3) 73.9 (12.1) 0.0108
Mean arterial pressure 89.9 (13.8) 92.0 (13.0) 0.0111
Ever Smoked (%) 44.1 74.7 b0.0001
History of Hypercholesterolemia (%) 86.2 80.7 0.0281
History of hypertension (%) 74.6 65.7 0.0021
History of diabetes 36.5 31.9 0.1188
Current medications (%)
Aspirin 36.5 39.1 0.385
Clopidogrel/Prasugrel/Ticagrelor 15.4 13.3 0.336
Nitrate 13.4 8.5 0.0081
Beta-blocker 25.4 21.6 0.1486
Calcium channel blocker 21.4 16.9 0.0614
ACE-inhibitor 21.9 19.8 0.4068
Angiotensin II receptor antagonist 29.3 21.6 0.0034
alpha-Blocker 2.3 2.6 0.7728
Statin 57.6 42.2 b0.0001
Other antianginal agent 3.7 2.6 0.2698
Data are presented as mean (±SD) or n (%).
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men with signiﬁcant coronary disease was higher for all age groups
but particularly from ages 45–59 years. The proportion of women
with signiﬁcant disease remained low until 60 years. Among men,
age increased the odds of having an extent score greater than zero, a
consistent relationship found for all age groups (χ2 P-value b0.0001).
Although the trendwas similar for women, the odds approached signif-
icance in the oldest group only (data not shown).
Table 4 shows the relationship between extent and vessel scores
with gender in the infarct and non-infarct group. There was no signiﬁ-
cant difference in the extent score between men and women who
presented with myocardial infarction (P = 0.179). The vessel score
however, was lower for the women compared to men (1.2 vs 1.6,
respectively, P = 0.005). Extent and vessel scores were signiﬁcantly
higher for men in the non-infarct group. Further, women without
infarction had lower extent and vessel scores than thosewith infarction
(P b 0.0001 for both). Extent and vessel scores were signiﬁcantly higher
in the infarct group for both sexes.
The predictors of extent score in men were age, systemic hyperten-
sion, body mass index, diabetes and evidence of recent myocardialTable 2
Mean average extent and vessel score for men and women.
Scoring system Male Female
n Mean (SD) n Mean (SD)
Extent score 712 36.8 (32.4)⁎a 282 19.6 (26.2)⁎b
Vessel score 712 1.3 (1.1)#a 282 0.7 (0.9)#b
Data are presented as mean (±SD) or n (%).
⁎# Males vs females P b 0.0001.
a Pearson correlation coefﬁcient for extent vs vessel score inmales r= 0.78, P b 0.0001.
b Pearson correlation coefﬁcient for extent vs vessel score in females r=0.74, P b 0.0001.infarction (Table 5). However in women, the predictors for extent
score in order of signiﬁcance were age, smoking, myocardial infarction
and hypercholesterolemia.
4. Discussion
We have shown a signiﬁcant difference in CAD severity and extent
between men and women presenting with suspected ischemic chest
pain. These ﬁndings are concordant with studies showing that
compared to men, age-matched women have a much lower burden of
obstructive and non-obstructive CAD [3,15–17]. We also found that
women with suspected ischemic chest pain undergoing invasive
coronary angiography had less extensive epicardial atheroma. There is
a paucity in the literature of data showing gender differences using
the extent scoring system to grade CAD.
The pattern of CAD inwomenwas found to be substantially different
to that inmen [2]. Pressurewire studies aswell as nuclear andmagnetic
resonance imaging have shown that women can display evidence of
myocardial ischemia and microvascular dysfunction in the absence of
obstructive coronary disease, often unrelated to the presence of
Framingham risk factors [8–10]. Further, women without signiﬁcant
luminal obstruction have a higher prevalence of atherosclerosis with
positive remodeling and preserved lumen size as demonstrated by
intravascular ultrasound (IVUS) [9,10]. A clear pathophysiologic expla-
nation for the observed sex-speciﬁc differences, however, is lacking.
Our study uses the Extent (Sullivan) score to determine the severity
and burden of coronary atherosclerosis in a large population presenting
for the evaluation of suspected angina [14]. We used the extent score as
an alternative method of analyzing CAD on angiography as it provides
anatomical perspective on atherosclerotic burden and has been shown
previously to be a potential marker of adverse outcome [18]. Bigi and
colleagues [18] studied 228 patients with low risk, stable CAD and
found the extent score determines the risk of death and myocardial
infarction. A recent study by Neeland et al. [19] showed that even in
the absence of signiﬁcant luminal stenosis, angiographic CAD scoring
systems are correlated with each other and with plaque burden as
determined by IVUS. A further IVUS study by Khuddus et al. [10] was
performed in a small population of women with suspected ischemia
and non-obstructive CAD. They reported that up to 80% of women
without signiﬁcant luminal narrowing, had a high prevalence of mild
to moderate atherosclerosis by IVUS. This suggests that traditional
methods of grading angiograms using stenosis scoring are suboptimal
in the female population and that an anatomical approach of examining
the burden and extent of atherosclerosis is perhaps a more useful tool.
In our population, beingmale led to amuch greater risk of signiﬁcant
CAD. Men showed a three-fold higher risk than women of having a
positive extent scorewhen presentingwith chest pain.We also showed
that for each ascending age-group, the mean adjusted score increased
substantially. Importantly, the proportion ofmenwith normal coronary
arteries fell dramatically after age 30–44 years, so that only approxi-
mately 16% of men aged 45–59 years and 12% of men aged 60–
74 years had normal coronary arteries. Compared to the youngest
group, being male aged over 45 years dramatically increased the odds
of having a positive extent score, compared to that in women, with
the odds increasing with ascending age.
This pattern was not seen in women.Women presenting with chest
pain had a lower CAD burden, with up to 50% having normal coronary
arteries in the 30–44 year age group and 40% in the 45–59 year age
group. Compared to men, women with chest pain were more likely to
have normal coronary arteries for each age band. Signiﬁcant CAD
appears to occur at a later age in women than men. Although there
was a trend of increasing risk of a positive score with age, it was only
of borderline signiﬁcance among women aged over 75 years. This
ﬁnding contrasts to that of men where the risk increased with age and
with extent score. This may suggest that the extent of atheroma is not
as predictive of the severity of CAD in women as it is for men.
Table 3
Association of gender and risk of extent score.
Gender
Extent score (n = 994)
0 1 2 3
n (%) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Female 282 (28) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Male 712 (72) 1 (reference) 2.45 (1.59,3.78) 2.81 (1.81,4.38) 3.13 (1.98,4.93)
Generalized logistic model. Adjusted for age, ethnicity, mean arterial blood pressure, body mass index, dyslipidemia, smoking, hypertension, presence of type 2 diabetes and nitrate
medication.
Chi-square for raw data P b 0.0001.
OR, odds ratio; CI, conﬁdence interval.
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of obstructive CAD in women presenting with angina. The Women's
Ischemia Syndrome Evaluation (WISE) study, found that the prevalence
of signiﬁcant CAD for females was b5% in women aged under 35 years
[2]. This changed dramatically from age 50 years but was highest from
age 65 years. A study by Lerner et al. [20] found that the rate of CAD
was low in women until age 75 years.
Enbergs et al. [21] studied 331 patients of which 39 men and 31
women had chest pain [21]. They reported higher extent scores in
men than women and that asymptomatic men had a lower score than
symptomatic men. In their study, women did not display differences
in their extent score by presentation. Our ﬁndings conﬂict to someFig. 1. Distribution of extent score by age grdegree with this study, albeit that our population was symptomatic.
Interestingly, women who presented with myocardial infarction had
lower extent scores than men, although this difference did not reach
statistical signiﬁcance. However, women without infarct had a much
lower score than those with evidence of recent infarction. These
ﬁndings suggest two interpretations: ﬁrst, the pathophysiology of
myocardial infarction may be similar for both genders and second, the
extent score may provide different information on the burden of
coronary artery atherosclerosis than traditional scoring systems
utilizing stenosis severity. This also suggests that CAD is more likely to
be diffuse in women as the number of signiﬁcant stenoses was found
to be less in women than in men.oup and gender for females and males.
Table 4
Extent and stenosis scores by gender in the infarct versus non-infarct groups.
Total Male Female r P
Extent score (0–100)
Total (n = 994) 31.9 (31.7) 36.8 (32.4) 19.6 (26.2) 0.254 b0.0001
Infarct (n = 221) 40.6 (26.9) 41.6 (26.9)⁎% 34.8 (26.5)#% 0.091 0.179
No infarct (n = 773) 29.5 (32.6) 35.2 (33.9)⁎$ 17.6 (25.6)#$ 0.252 b0.0001
Vessel score (0–3)
Total (n = 994) 1.2 (1.1) 1.3 (1.1) 0.8 (0.9) 0.261 b0.0001
Infarct (n = 221) 1.6 (0.8) 1.6 (0.8)a& 1.2(0.6)b& 0.15 0.011
No infarct (n = 773) 1.1 (1.1) 1.2 (0.8)a§ 0.6 (0.9)b§ 0.218 b0.0001
Independent t-test to compare gender and average extent and vessel score.
Values are Mean (SD); r = correlation coefﬁcient adjusted for age.
Extent score: ⁎Male infarct vs non-infarct, P = 0.02; #female infarct vs non-infarct P b 0.0001; %male vs female infarct, P = 0.179; $male vs female non-infarct, P b 0.0001.
Vessel score: aMale infarct vs non-infarct, P b 0.0001; bfemale infarct vs non-infarct P b 0.0001.
&Male vs female infarct, P = 0.005; §male vs female non-infarct, P b 0.0001.
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graphic ﬁndings among men and women presenting with myocardial
infarction. Milcent et al. [22] studied a large series of patients who
presented with acute myocardial infarction and found that women
had a higher mortality [22]. Further, it has been previously described
that the mortality in both ST elevation and non-ST elevation acute
coronary syndrome was higher for women despite a lower incidence
of obstructive CAD [3,4].
The ability of myocardial infarction to predict the extent score was
demonstrated by themultivariate analysis showing amoderately strong
positive association for men and women. Our study found that predic-
tors of extent score in men were older age, systemic hypertension,
body mass index, diabetes and myocardial infarction. By contrast, the
predictors in women were older age, smoking, hyperlipidemia and
recent myocardial infarction. Horimoto et al. found similar predictors,
though in contrast, diabetes was a predictor among women and
smoking among men in their study of 437 patients with suspected
CAD [23]. We found that traditional risk factors were less predictive of
the extent score in women than in men, except smoking, which is a
powerful predictor. As such, despite risk factors being more predictive
of future cardiovascular events in women [24,25], there is a disconnect
in predicting the overall burden of coronary atheroma. We should
therefore be cautious when reassuring women in the presence of
normal arteries or minor CAD.
The difference in the burden of CAD between men and women
presenting with chest pain has potential clinical implications. Our study
suggests that traditional invasive coronary angiography may not always
assist in establishing the cause of symptoms in women presenting with
suspected ischemic chest pain. Using the Extent score may be a useful
adjunct to traditional angiogram analyses to further risk stratify
women. Angiography provides falsely reassuring results in women
when there is minimal obstructive disease as they continue to have
recurrent hospital admissions, repeated investigations for persistent
or progressive symptoms and higher cardiovascular event rates
[26–29]. We need to investigate the utility of non-invasive methods as
well as examine the role of non-traditional riskmarkers in the diagnosisTable 5
Multivariate predictors of extent score by gender.
Variable Male (χ2) P Female (χ2) P
Age 50.6 b0.0001 21.5 0.011
Systemic hypertension 9.3 0.026 0.3 0.97
Body mass index 9.4 0.024 1.3 0.73
Diabetes 27.4 b0.0001 5.1 0.16
Cigarette smoker 6.9 0.077 15.3 0.002
Hypercholesterolemia 5.4 0.144 4.8 0.028
Infarction 9.6 0.022 8.6 0.035
Chi-squared (χ2) test for predictors of extent score.
P-values signiﬁcant at P b 0.05.of angina in the female population. From there, an optimal approach to
treatment and prevention can be made.4.1. Limitations
Although this is a large study from a single center examining
patients from a broad demographic, all our patients were symptomatic
and being investigated for suspected ischemia and therefore there
was no predeﬁned or standardized patient population. This limits the
generalizability of our results to similar care settings and the general
population. Further, the low proportion of women recruited in the
study may have inﬂuenced the outcomes. This does highlight the
lower number of women presenting for coronary angiography as well
as the perceived lower risk of ischemic heart disease. Selection bias
cannot be completely excluded even after adjusting for a wide range
of patient characteristics. Last, we did not collect information on non-
invasive investigations (such as stress testing, myocardial perfusion
imaging) performed preceeding angiography as these were not avail-
able. Further, we were unable to perform novel ancillary investigations
such as coronary ﬂow reserve, PET scan or cardiac MRI which would be
useful to correlate the ﬁndings.5. Conclusions
We found a signiﬁcant contrast in CAD severity and burden between
women and men presenting for the investigation of suspected angina.
Even in the presence of traditional risk factors, womenweremore likely
to have normal coronary arteries or less severe disease than men.
The extent score may be a useful tool to determine the diffusion of ath-
erosclerosis seen on invasive coronary angiography and may help risk
stratify CAD in women. Future studies should correlate the extent
score with pressure wire studies, coronary artery calciﬁcation, myocar-
dial perfusion imaging and/or PET scanning to determine if higher scores
infer a predictive value for ischemia or microvascular dysfunction.Disclosures and competing interests
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